Phreesia Total Long-Term Assets 2019-2025 | PHR

Phreesia total long-term assets from 2019 to 2025. Total long-term assets can be defined as the sum of all assets classified as non-current
Phreesia Annual Total Long-Term Assets
(Millions of US $)
2025 $185
2024 $175
2023 $108
2022 $108
2021 $54
2020 $27
2019 $26
2018 $0
Phreesia Quarterly Total Long-Term Assets
(Millions of US $)
2025-01-31 $185
2024-10-31 $186
2024-07-31 $181
2024-04-30 $181
2024-01-31 $175
2023-10-31 $175
2023-07-31 $121
2023-04-30 $114
2023-01-31 $108
2022-10-31 $110
2022-07-31 $109
2022-04-30 $110
2022-01-31 $108
2021-10-31 $65
2021-07-31 $58
2021-04-30 $54
2021-01-31 $54
2020-10-31 $36
2020-07-31 $32
2020-04-30 $31
2020-01-31 $27
2019-10-31 $27
2019-07-31 $27
2019-04-30
2019-01-31
2018-10-31
2018-07-31
2018-01-31
Sector Industry Market Cap Revenue
Medical Medical Information Systems $1.492B $0.420B
Phreesia Inc. provides a patient intake management platform. The company's SaaS platform engages patients in their care and provides a modern, consistent experience, while enabling healthcare organizations to optimize their staffing, boost profitability and enhance clinical care. Phreesia Inc. is based in New York.
Stock Name Country Market Cap PE Ratio
Veeva Systems (VEEV) United States $38.971B 53.83
Hims & Hers Health (HIMS) United States $11.505B 119.54
Tempus AI (TEM) United States $11.232B 0.00
Inspire Medical Systems (INSP) United States $4.506B 70.41
IRhythm Technologies (IRTC) United States $4.374B 0.00
Privia Health (PRVA) United States $3.041B 208.92
Clover Health Investments (CLOV) United States $1.916B 0.00
Enovis (ENOV) United States $1.889B 10.53
Schrodinger (SDGR) United States $1.744B 0.00
Azenta (AZTA) United States $1.266B 58.96
Omnicell (OMCL) United States $1.189B 20.98
10x Genomics (TXG) United States $1.055B 0.00
Fulgent Genetics (FLGT) United States $0.565B 0.00
Butterfly Network (BFLY) United States $0.561B 0.00
Talkspace (TALK) United States $0.512B 152.00
Veradigm (MDRX) United States $0.486B 0.00
Standard BioTools (LAB) United States $0.424B 0.00
TruBridge (TBRG) United States $0.374B 833.33
Claritev (CTEV) United States $0.350B 0.00
Health Catalyst (HCAT) United States $0.293B 0.00
Nyxoah SA (NYXH) Belgium $0.211B 0.00
SOPHiA GENETICS SA (SOPH) Switzerland $0.199B 0.00
Pulmonx (LUNG) United States $0.147B 0.00
EUDA Health Holdings (EUDA) Singapore $0.146B 0.00
American Well (AMWL) United States $0.109B 0.00
Retrieve Medical Holdings (RMHI) United States $0.094B 0.00
MDxHealth SA (MDXH) Belgium $0.086B 0.00
CareCloud (CCLD) United States $0.078B 2.97
111 (YI) China $0.066B 0.00
P3 Health Partners (PIII) United States $0.061B 0.00
HeartBeam (BEAT) United States $0.061B 0.00
Outset Medical (OM) United States $0.057B 0.00
Zepp Health (ZEPP) Netherlands $0.040B 0.00
Zhongchao (ZCMD) China $0.028B 0.00
ImmunoPrecise Antibodies (IPA) Canada $0.021B 0.00
Bullfrog AI Holdings (BFRG) United States $0.017B 0.00
MSP Recovery (MSPR) United States $0.016B 0.00
Streamline Health Solutions (STRM) United States $0.011B 0.00
Healthcare Triangle (HCTI) United States $0.010B 0.00
Strata Skin Sciences (SSKN) United States $0.010B 0.00
Precipio (PRPO) United States $0.010B 0.00
Predictive Oncology (POAI) United States $0.010B 0.00
Movano (MOVE) United States $0.006B 0.00
Mobile-health Network Solutions (MNDR) Singapore $0.004B 0.00
HeartSciences (HSCS) United States $0.004B 0.00
Tivic Health Systems (TIVC) United States $0.003B 0.00
Future Health ESG (FHLT) United States $0.000B 0.00